bf/NASDAQ:FORM_icon.png

COM:FORMFACTOR

FormFactor

  • Stock

USD

Last Close

40.78

22/11 21:00

Market Cap

4.76B

Beta: -

Volume Today

500.56K

Avg: -

Company Overview

Metric
Company NameFormFactor, Inc.medmix
SymbolFORM
MSH IDCOM:FORMFACTORSWISS:MEDMIX
MarketSTOCKSPRIVATE
SectorTechnologyHealthcare & Health Services
IndustrySemiconductorsMedical Devices
CountryUSCH
Stage
Employee Count2.12K1.00K
Websiteformfactor.commedmix.swiss
LinkedInformfactormedmix
Founders

Market Metrics

Metric
Market Cap4.76B
Enterprise Value
Monthly Web Traffic19.51K15.86K
Web Traffic Growth-0.24-0.52
Valuation
Raised Capital

Financial Performance

Metric
Revenue663.10M
Revenue (LTM)
Revenue (NTM)
Gross Profit258.58M
EBITDA82.76M
Operating Income82.76M
Net Income82.39M
EPS1.06
Diluted EPS1.05
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.41
Operating Profit Margin0.04
EBITDA Margin0.12
Net Profit Margin0.17
Return on Equity0.13
Return on Assets0.10
Return on Capital Employed0.03

Valuation Multiples

Metric
P/E Ratio-426.45
P/B Ratio3.65
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio7.23
EV Multiple122.11

Operational Metrics

Metric
Days Sales Outstanding49.13
Days Payables Outstanding52.88
Days Inventory Outstanding100.77
Operating Cycle161.10
Cash Conversion Cycle106.95
Asset Turnover0.61

Cash Flow Metrics

Metric
Operating Cash Flow64.60M
Free Cash Flow8.57M
Cash Flow to Debt3.83
Operating Cash Flow/Sales0.13
Free Cash Flow Yield0.00

Balance Sheet Metrics

Metric
Cash & Equivalents178.96M
Accounts Receivable-23.30M
Inventory111.69M
Goodwill201.09M
Debt to Capitalization0.04
Debt to Assets0.05
Current Ratio3.91
Quick Ratio3.67

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.06
R&D to Revenue0.17
SG&A to Revenue0.05